Stock listing
520394 Stock Price, News, Filings & Events — Brain Biotech Ag
Selected listing: 520394 · LSX · EUR · DE
This page tracks Brain Biotech Ag's 520394:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 520394:LSX. 520394:LSX is the stock-level entry point for investors researching Brain Biotech Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 520394:LSX
- Asset type
- Stock
- Market cap
- $67.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Brain Biotech Ag 520394:LSX stock context
This page tracks Brain Biotech Ag's 520394:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 520394:LSX. 520394:LSX is the stock-level entry point for investors researching Brain Biotech Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Brain Biotech Ag
BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma
September 9, 2026
Dr. Sven K. Weber Succeeds Adriaan Moelker as CEO of BRAIN Biotech AG
July 29, 2026
BRAIN Biotech AG signs new Revolving Credit Facility with MP Beteiligungs-GmbH
July 13, 2026
BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance
May 28, 2026
BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
March 23, 2026
Research Brain Biotech Ag
Brain Biotech Ag investor report
Review AI stock analysis and investor report context for 520394:LSX.
Brain Biotech Ag company profile
View the public company page for Brain Biotech Ag on 6ix.
Brain Biotech Ag news
Read company news and market updates connected to Brain Biotech Ag.
Brain Biotech Ag investor events
Find investor webinars, events, and replay context for Brain Biotech Ag.
Alternate listings
BNN:XETR
DE · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
BNN:TRADEGATE
DE · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
BNN:GETTEX
DE · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
0RFI:LSE
GB · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
BNN:FWB
DE · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
520394:LS
DE · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
BNND:AQUISEU
GB · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
BNN:BX
CH · CHF
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
BNN:DUS
DE · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
BNN:MUN
DE · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
BNN:HAM
DE · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.
BNN:SWB
DE · EUR
Alternate listing for Brain Biotech Ag; the primary context on this page is 520394:LSX.